PACAP Protects Against Salsolinol-Induced Toxicity in Dopaminergic SH-SY5Y Cells: Implication for Parkinson’s Disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PACAP Protects Against Salsolinol-Induced Toxicity in Dopaminergic SH-SY5Y Cells: Implication for Parkinson’s Disease
Authors
Keywords
PACAP, Salsolinol, SH-SY5Y cell line, Neuroprotection, Apoptosis, BDNF, p-CREB
Journal
JOURNAL OF MOLECULAR NEUROSCIENCE
Volume 50, Issue 3, Pages 600-607
Publisher
Springer Nature
Online
2013-05-01
DOI
10.1007/s12031-013-0015-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding the substrate specificity of conventional calpains
- (2012) Hiroyuki Sorimachi et al. BIOLOGICAL CHEMISTRY
- Updates in the medical management of Parkinson disease
- (2012) H. H. FERNANDEZ CLEVELAND CLINIC JOURNAL OF MEDICINE
- Effect of PACAP in Central and Peripheral Nerve Injuries
- (2012) Andrea Tamas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-6 and PACAP Receptor Expression and Localization after Global Brain Ischemia in Mice
- (2012) Tomoya Nakamachi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Neuroprotective Effect of Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide on Spinal Cord Injury
- (2012) Daisuke Tsuchikawa et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Multimodal Neuroprotection Induced by PACAP38 in Oxygen–Glucose Deprivation and Middle Cerebral Artery Occlusion Stroke Models
- (2012) Philip Lazarovici et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- PACAP is an Endogenous Protective Factor—Insights from PACAP-Deficient Mice
- (2012) D. Reglodi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Cyclic AMP response element-binding protein (CREB) phosphorylation: A mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics
- (2011) R. Scott Bitner BIOCHEMICAL PHARMACOLOGY
- Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo
- (2011) D. Reglodi et al. CURRENT PHARMACEUTICAL DESIGN
- Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice
- (2011) Dorothea Rat et al. FASEB JOURNAL
- Antioxidant and Anti-Apoptotic Activity of Vasoactive Intestinal Peptide (VIP) Against 6-Hydroxy Dopamine Toxicity in the Rat Corpus Striatum
- (2011) Neşe Tunçel et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Mice Deficient in Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) are More Susceptible to Retinal Ischemic Injury In Vivo
- (2011) K. Szabadfi et al. NEUROTOXICITY RESEARCH
- Comparative Examination of Inner Ear in Wild Type and Pituitary Adenylate Cyclase Activating Polypeptide (PACAP)-Deficient Mice
- (2011) A. Tamas et al. NEUROTOXICITY RESEARCH
- Toxic Effects of Low Alcohol and Nicotine Combinations in SH-SY5Y Cells are Apoptotically Mediated
- (2011) Carlana Ramlochansingh et al. NEUROTOXICITY RESEARCH
- The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice
- (2010) Ning Li et al. ACTA PHARMACOLOGICA SINICA
- Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF
- (2010) Elena Puerta et al. NEUROBIOLOGY OF DISEASE
- Neuroprotective Effects of PACAP Against Ethanol-Induced Toxicity in the Developing Rat Cerebellum
- (2010) Béatrice Botia et al. NEUROTOXICITY RESEARCH
- When and how should treatment be started in Parkinson disease?
- (2009) A. E. Lang NEUROLOGY
- Additive Protective Effects of Donepezil and Nicotine Against Salsolinol-Induced Cytotoxicity in SH-SY5Y Cells
- (2009) Jharna R. Das et al. NEUROTOXICITY RESEARCH
- Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
- (2009) D. Vaudry et al. PHARMACOLOGICAL REVIEWS
- Isolation of Peptide Transport System-6 from Brain Endothelial Cells: Therapeutic Effects with Antisense Inhibition in Alzheimer and Stroke Models
- (2008) Dilek Dogrukol-Ak et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity
- (2008) T.S. Guillot et al. NEUROPEPTIDES
- Neuroprotective effects of PACAP27 in mice model of Parkinson’s disease involved in the modulation of KATP subunits and D2 receptors in the striatum
- (2008) Gang Wang et al. NEUROPEPTIDES
- The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells
- (2007) D. Jantas et al. NEUROCHEMISTRY INTERNATIONAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started